Dr. Diaz on Response Rates for MSI-H and NTRK Fusions in GI Cancer

Luis A. Diaz, MD
Published: Tuesday, Dec 12, 2017



Luis A. Diaz, MD, head of the division of Solid Tumor Oncology at Memorial Sloan Kettering Cancer Center, discusses the responses seen with microsatellite-instability high (MSI-H) and NTRK fusions in patients with gastrointestinal cancer.

MSI and NTRK fusions are present at a low level in multiple different tumor types. If found, the patient has dramatic responses that may be experienced for years, explains Diaz.

Further long-term research is needed to determine if these patients will achieve long-term survival or if they will progress, says Diaz.
 


Luis A. Diaz, MD, head of the division of Solid Tumor Oncology at Memorial Sloan Kettering Cancer Center, discusses the responses seen with microsatellite-instability high (MSI-H) and NTRK fusions in patients with gastrointestinal cancer.

MSI and NTRK fusions are present at a low level in multiple different tumor types. If found, the patient has dramatic responses that may be experienced for years, explains Diaz.

Further long-term research is needed to determine if these patients will achieve long-term survival or if they will progress, says Diaz.
 

View Conference Coverage
Online CME Activities
TitleExpiration DateCME Credits
Clinical Vignette Series: 34th Annual Chemotherapy Foundation Symposium: Innovative Cancer Therapy for Tomorrow®Feb 28, 20182.0
Medical Crossfire®: Bridging Emerging Data to Advance Treatment Planning for Hepatocellular Carcinoma: A Multidisciplinary Tumor BoardMar 31, 20182.0
Publication Bottom Border
Border Publication
x